hemophagocyt
lymphohistiocytosi
hlh
aggress
inflammatori
syndrom
high
mortal
result
inappropri
activ
immun
system
lymphocyt
macrophag
hlh
appear
affect
age
although
hereditari
sporad
case
report
often
children
incid
hlh
sweden
estim
children
per
million
children
per
year
live
birth
equal
sex
distribut
patient
hlh
sign
symptom
similar
sever
infect
fever
splenomegali
hepatomegali
lymphadenopathi
jaundic
patient
intens
inflammatori
respons
shown
high
product
proinflammatori
cytokin
interferon
tumor
necrosi
factor
solubl
receptor
inappropri
activ
cell
macrophag
high
cytokin
cascad
may
lead
multiorgan
failur
death
laboratori
test
show
cytopenia
hypertriglyceridemia
elev
ferritin
alter
hepat
enzym
sign
hemolysi
hyperbilirubinemia
elev
lactat
dehydrogenas
alter
coagul
system
low
fibrinogen
dissemin
intravascular
coagul
histopatholog
sign
includ
hemophagocytosi
bonemarrow
spleen
lymph
node
activ
macrophag
engulf
matur
blood
cell
precursor
diagnost
criteria
includ
clinic
laboratori
find
relationship
acut
chronic
ebv
infect
develop
hlh
describ
case
report
children
adolesc
major
east
asia
hlh
also
secondari
condit
autoimmun
disord
adultonset
still
diseas
malign
particularli
cell
lymphoma
viral
bacteri
fungal
parasit
infect
immunosuppress
patient
xlink
lymphoprolif
syndrom
rare
disord
affect
male
develop
hlh
infect
viru
case
report
describ
clinic
cours
treatment
patient
hlh
caus
reactiv
ebv
infect
patient
woman
tablettr
diabet
mellitu
present
fever
pain
throat
skin
rash
primari
care
receiv
antibiot
due
high
crp
sediment
rate
sr
fever
persist
patient
admit
hospit
concentr
inflammatori
variabl
pcrp
b
leukocyt
high
suspicion
underli
bacteri
infect
patient
receiv
intraven
antibiot
cefotaxim
without
respons
due
deterior
low
systol
blood
pressur
confus
intens
skin
rash
arm
leg
chestabdomen
fever
admit
intens
care
unit
blood
plasma
test
show
high
ferritin
level
still
diseas
suspect
bloodplasma
test
show
sign
dissemin
intravascular
coagul
dic
high
protrombinkomplex
intern
normal
ratio
pkinr
high
activ
partial
thromboplastin
time
apt
elev
fibrin
ddimer
success
low
fibrinogen
patient
high
crp
mgl
blood
sediment
rate
mmh
anemia
gl
thrombocytopenia
leukopenia
procalcitonin
time
higher
normal
initi
antibiot
treatment
chang
meropenem
gensumycin
fluconazol
despit
treatment
antibiot
antifung
medic
signific
improv
seen
addit
blood
plasma
test
show
high
triglycerid
valu
solubl
exceed
kul
indic
high
cytokin
product
patient
five
eight
criteria
hlh
therebi
diagnosi
confirm
sever
biopsi
perform
order
find
underli
diseas
without
success
bonemarrow
biopsi
show
slight
alter
matur
megakaryocyt
erythropoiesi
sign
lymphoma
malign
initi
phase
myelodysplast
syndrom
could
exclud
later
bonemarrow
biopsi
could
confirm
diagnosi
biopsi
skin
show
nonspecif
inflamm
edema
infiltr
lymphocyt
round
blood
vessel
sign
vascul
necros
granuloma
petct
scan
perform
order
evalu
possibl
enhanc
uptak
reflect
augment
metabol
typic
eg
malign
scan
show
symmetr
bilater
uptak
lymph
node
neck
mediastinum
lung
hili
liver
hilum
along
iliaca
externa
inguin
region
spleen
figur
uptak
strongest
lymph
node
neck
spleen
could
detect
antibodi
parvoviru
human
immunodeffici
viru
hiv
human
immunodeffici
viru
hhv
influenza
b
adenoviru
coronaviru
respiratori
syncyti
viru
rsv
b
rhinoviru
parainfluenza
rsv
b
nasopharynx
neg
elev
igg
hsv
varicella
zoster
viru
vzv
igmneg
virus
preexist
clinic
featur
background
chronic
activ
ebv
infect
patient
sign
previou
infect
ebv
ebna
repeat
test
presenc
igg
despit
patient
ebv
load
copiesml
whole
blood
dna
new
assess
ebv
igg
neg
day
later
bacteri
fungal
infect
found
despit
repeat
cultur
urin
blood
sputum
bonemarrow
accord
geneticist
fact
patient
woman
year
old
medic
histori
dysgammaglobulinemia
lymphoma
xlink
prolif
syndrom
improb
patient
age
show
familiar
form
hlh
unlik
clinic
present
typic
morbu
still
rheumatolog
diseas
malign
could
confirm
treatment
steroid
start
first
mg
prednisolon
mg
dexamethason
durat
therapi
month
day
dose
gradual
decreas
therapi
discontinu
patient
good
respons
steroid
therapi
treatment
etoposid
cyclosporin
necessari
clinic
condit
patient
improv
week
treatment
steroid
fever
disappear
blood
pressur
gener
condit
improv
skin
rash
decreas
hemoglobin
increas
gl
gl
platelet
within
week
ferritin
decreas
coupl
week
patient
intens
fatigu
convalesc
admit
rehabilit
unit
train
improv
gener
condit
gradual
seen
period
latest
followup
visit
patient
feel
well
normal
plasma
ferritin
sign
hlh
activ
case
one
report
case
serolog
evid
prior
ebv
infect
howev
studi
show
strong
correl
hlh
acut
ebv
infect
patient
fulmin
syndrom
sepsislik
pattern
dissemin
intravascular
coagul
need
intens
care
treat
broadspectrum
antibiot
antifung
without
effect
good
clinic
respons
given
steroid
remark
patient
extrem
elev
procalcitonin
without
sign
bacteri
infect
could
relat
cytokin
storm
secondari
patient
diseas
mean
condit
high
product
cytokin
make
difficult
use
procalcitonin
differenti
sever
bacteri
infect
ebvinduc
hlh
extrem
elev
plasma
ferritin
typic
hlh
patient
fulfil
criteria
hlh
wellknown
associ
infect
develop
hlh
infect
viral
bacteri
fungal
parasit
polymeras
chain
reaction
pcr
posit
ebv
acut
phase
diseas
indic
patient
reactiv
previou
ebv
infect
even
though
posit
ebna
rare
condit
incid
probabl
underestim
due
lack
awar
diagnost
criteria
similar
initi
clinic
present
wide
varieti
inflammatori
infect
disord
criteria
establish
henter
et
al
use
guid
diagnosi
presenc
neutral
antibodi
exclud
reactiv
ebv
subsequ
otherwis
immunecompet
individu
treatment
protocol
includ
induct
therapi
dexamethason
etoposid
follow
continu
treatment
cyclosporin
puls
dexamethason
etoposid
sometim
treatment
dexamethason
cyclosporin
start
etoposid
ad
necessari
patient
receiv
treatment
dexamethason
good
clinic
laboratori
respons
addit
etoposid
cyclosporin
necessari
patient
surviv
despit
sever
clinic
condit
diagnos
earli
proper
treatment
given
similar
case
report
sweden
knowledg
